Avalon GloboCare shows 490,197 shares (7.0%) owned
Rhea-AI Filing Summary
Avalon GloboCare Corp. reporting persons Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC jointly state beneficial ownership of 490,197 shares of Common Stock, representing 7.0% of the outstanding common stock based on 7,042,348 shares outstanding as of February 27, 2026.
The filing excludes two warrants held by Intracoastal (each exercisable into 490,197 shares) because each warrant is not exercisable until stockholder approval of the issuances and contains a blocker provision limiting exercise to prevent ownership above 4.99%. Without those blocker provisions (and if exercisable), the reporting persons may be deemed to beneficially own 1,470,591 shares.
Positive
- None.
Negative
- None.
Insights
Joint 13G reports shared control of 490,197 shares (7.0%) and discloses warrant blockers.
The filing lists 490,197 shares beneficially owned by the Reporting Persons and ties that to 7,042,348 shares outstanding as of February 27, 2026, giving a 7.0% stake. It also explains two warrants exercisable into matching amounts are excluded because they are not currently exercisable and include a blocker provision.
Key dependencies include stockholder approval for the warrant issuances and the blocker limits to 4.99%; subsequent disclosures or approvals would change reported ownership percentages.
Disclosure follows Schedule 13G mechanics: current beneficial ownership, exclusions for unexercisable warrants, and ownership caps.
The report attributes shared voting and dispositive power for 490,197 shares to the reporting group and explicitly excludes two warrants pending stockholder approval. The filing preserves the literal "blocker provision" language limiting exercises above 4.99%.
Any change in exercisability or stockholder approvals would require updated filings reflecting altered beneficial ownership; timing and approvals are not stated here.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does ALBT reporting persons hold according to this Schedule 13G?
What is the effect of the "blocker provision" mentioned in the ALBT filing?
How would ownership change if the warrants were exercisable without blockers?
Who are the reporting persons named in the Schedule 13G for ALBT?
What voting and dispositive powers are reported for these ALBT holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.